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Increased Sensitivity to N-Methyl-D-Aspartate
Receptor-Mediated Excitotoxicity
in a Mouse Model of Huntington’s Disease
cortical afferents and activation of the ionotropic gluta-
mate receptors: the N-methyl-D-aspartate (NMDAR),
-amino-3-hydroxy-5-methyl-4- isoxazolepropionate
(AMPAR), and kainic acid (KAR) (DiFiglia, 1990; Beal,
1992). Results of radiolabeled ligand binding assays in
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human postmortem tissue indicated that striatal gluta-Department of Psychiatry
mate receptors show disproportionate loss in HD, and2 Section for Neuronal Survival
NMDAR binding was significantly decreased in this re-Wallenberg Neuroscience Center
gion even in the presymptomatic stage of the disease,Lund University
suggesting that neurons which highly express these re-The Biomedical Center A10
ceptors may be most vulnerable (Young et al., 1988;221 84 Lund
Albin et al., 1990). In rodents, intrastriatal injection ofSweden
kainic acid resulted in death of most neurons with pres-3 Centre for Molecular Medicine and Therapeutics
ervation of glia and afferents (Coyle and Schwarcz, 1976;Department of Medical Genetics
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of nonhuman primates resulted in behavioral, neuro-Canada
chemical, and neuropathological abnormalities that
mimicked the changes seen in HD (Hantraye et al., 1990).
Finally, systemic injection of mitochondrial toxins suchSummary
as malonate also caused striatal degeneration typical
of HD; this neuronal loss was blocked by the NMDARPrevious work suggests N-methyl-D-aspartate recep-
antagonist MK-801 (Greene et al., 1993). Although thesetor (NMDAR) activation may be involved in degenera-
data support the hypothesis that NMDAR-mediated ex-tion of medium-sized spiny striatal neurons in Hunting-
citotoxicity may play a critical role in the pathogenesiston’s disease (HD). Here we show that these neurons
of HD, the evidence until now has been indirect.are more vulnerable to NMDAR-mediated death in a
The results of studies outlined above also raise theYAC transgenic FVB/N mouse model of HD expressing
question of whether mutant htt expression can causefull-length mutant huntingtin, compared with wild-type
increased activity of NMDARs or their downstream ef-FVB/N mice. Excitotoxic death of these neurons was
fectors of cell death and how such interactions mightincreased after intrastriatal injection of quinolinate in
explain selective neuronal vulnerability. Recent datavivo, and after NMDA but not AMPA exposure in culture.
strongly support roles for caspase activation, and/orNMDA-induced cell death was abolished by an NR2B
formation of toxic aggregates of htt containing the polyQsubtype-specific antagonist. In contrast, NMDAR-
tract, in the neuronal degeneration underlying HD andmediated death of cerebellar granule neurons was not
related neurodegenerative diseases caused by genesenhanced, consistent with cell-type and NMDAR sub-
with a triplet repeat expansion (reviewed by Wellingtontype specificity. Moreover, increased NMDA-evoked
and Hayden, 2000). However, each of these diseasescurrent amplitude and caspase-3 activity were ob-
has a distinct pattern of selective neuronal death, so
served in transgenic striatal neurons. Our data sup-
the upstream events that trigger caspase activation and
port a role for NR2B-subtype NMDAR activation as a protein aggregation may be unique for each disease
trigger for selective neuronal degeneration in HD. and related to interactions between mutant protein and
other proteins that are selectively expressed in vulnera-
Introduction ble neuronal populations. We have previously reported
enhancement of NMDAR-mediated current amplitude
Huntington’s disease (HD), inherited in an autosomal and apoptosis in cell lines expressing full-length mutant
dominant fashion, is characterized by progressive neu- htt and the NR1A/NR2B but not NR1A/NR2A subtype of
rodegeneration resulting in a movement disorder, emo- NMDARs (Chen et al., 1999; Zeron et al., 2001). Notably,
tional disturbances, and cognitive decline (Harper, MSNs primarily express the NR1A and NR2B subunits
1991). HD is caused by a polyglutamine (polyQ) expan- (Landwehrmeyer et al., 1995; Kuppenbender et al.,
sion in the N-terminal region of the protein huntingtin 1999), whereas other forebrain regions express combi-
(htt) (HDCRG, 1993). Although it is not known why the nations of both NR2A and NR2B with a variety of NR1
GABAergic, medium-sized spiny neurons (MSNs) of the splice variants, and the cerebellum and brain stem lack
striatum are preferentially targeted for degeneration in NR2B (Hollmann and Heinemann, 1994; Monyer et al.,
HD, a body of evidence supports a role for excitotoxic 1994; Thompson et al., 2000; Kovacs et al., 2001). There-
cell death mediated by the release of glutamate from fore, we hypothesized that in MSNs, full-length mutant
htt acts to augment NMDAR activity, resulting in in-
creased caspase activation and cell death.6 Correspondence: lynnr@interchange.ubc.ca
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Figure 1. Increased Number of Dying Neu-
rons in YAC72 Mice after NMDAR-Induced
Excitotoxicity In Vivo
The number of dying neurons 72 hr after intra-
striatal injection of quinolinic acid was de-
tected using the fluorescent neuronal death
marker Fluoro-Jade. Photomicrographs
show coronal sections at the level of the stria-
tum of 10-month-old wild-type (A) and YAC72
mice (D). (B) Fluoro-Jade stained neurons at
higher magnification in a lesioned striatum.
(E) Very low level of background staining in
the contralateral unlesioned side of the stria-
tum. (Scale bars  710 m [A and D] and 23
m [B and E]). Quantification revealed in-
creases in lesion volume (C) and numbers of
Fluoro-Jade stained, dying neurons (F) in
YAC72 mice (closed bars) compared to wild-
type mice (open bars). Data are presented as
mean  SEM (n  3 per group for 6-month-
old mice, and n  6–7 per group for 10-
month-old mice). *Significantly different com-
pared to littermate control, p  0.025.
We tested our hypothesis in a transgenic mouse model, tive), as well as nonpyknotic neurons (cresyl violet), was
significantly reduced in the striatum of YAC72 mice com-described by Hodgson et al. (1999), in which FVB/N mice
express a yeast artificial chromosome (YAC) containing pared with wild-type (Figure 2). These data support our
hypothesis that striatal neurons expressing the mutantthe full-length human HD gene including all endogenous
regulatory elements with an expanded (46 or 72) CAG form of htt are more vulnerable to NMDAR-mediated
cell death.repeat (YAC46 or YAC72 mice). This model optimizes
normal developmental and cell-specific regulation of
full-length htt expression, and YAC72 mice show pro- Enhanced Excitotoxicity in Cultured Neonatal
gressive neurobehavioral changes and selective striatal MSNs Expressing Mutant htt
neurodegeneration similar to that seen in HD (Hodgson Increased vulnerability to NMDAR-mediated striatal cell
et al., 1999). In this study we tested whether MSNs from death in 6- and 10-month-old YAC72 mice might be a
YAC46 and/or YAC72 mice display enhanced NMDA- consequence of other cellular changes resulting from
mediated excitotoxic cell death, current influx, and cas- mutant htt expression, since around this age, the mice
pase activation when compared with MSNs from wild- show electrophysiological abnormalities and an HD-like
type FVB/N mice. phenotype (Hodgson et al., 1999). To help determine
whether augmented sensitivity to NMDAR activation is
a primary mechanism underlying increased striatal neu-Results
ronal degeneration in vivo, we tested whether MSNs
from young (early postnatal) YAC72 mice also exhibitEnhanced Excitotoxicity in MSNs Expressing
Mutant htt In Vivo enhanced vulnerability to NMDAR agonists. We used an
in vitro model of excitotoxicity, treating primary neostria-To compare susceptibility to NMDAR-mediated excito-
toxicity, the NMDAR agonist quinolinic acid was injected tal cultures with NMDA and glycine for 10 min and as-
sessing cell survival 24 hr later, similarly to models usedunilaterally into the striatum of 6- and 10-month-old
YAC72 mice and their wild-type littermates. Large num- by others to investigate mechanisms of excitotoxicity
(reviewed by Choi, 1988). Numbers of MSNs (assessedbers of striatal neurons died after intrastriatal injection of
quinolinic acid in both wild-type and YAC72 transgenic by morphological criteria) remaining attached to the dish
were similar between the cultures from YAC72 and wild-mice, as shown in sections stained with Fluoro-Jade (Fig-
ure 1), a fluorescent marker of dying neurons (Schmued type mice (data not shown). NMDA-induced cell death,
as measured by percentage of MSNs with trypan blueet al., 1997; Hansson et al., 1999). However, the number
of dying striatal cells was significantly greater in YAC72 inclusion, was dose dependent [two-factor ANOVA, ef-
fect of concentration F(2,29)  41.2, p  0.0001]; it wastransgenic compared to wild-type mice (Figure 1). As
previously reported by Beal et al. (1986), we found that nearly 2-fold larger after a supramaximal concentration
of 3 mM than after 100 M (Figure 3A), which is closequinolinic acid predominantly targeted the same popu-
lation of striatal neurons (MSNs) that degenerate in hu- to the measured EC50 for NMDAR currents recorded
from murine cortical and diencephalic neurons (Satherman HD. Interestingly, following quinolinate injection,
the number of surviving MSNs (DARPP-32 immunoreac- et al., 1992). As well, brief (20 min) exposures to NMDA
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cated that at 3 mM NMDA treatment, both the mutant
htt groups displayed significantly more apoptosis than
wild-type cultures (Bonferroni post hoc test; wild-type
versus 46Q, p  0.05; wild-type versus 72Q, p  0.001)
and the 72Q group exhibited significantly more apopto-
sis than the 46Q group (Bonferroni post hoc test, p 
0.05) (Figures 3C and 3D). These in vitro data indicate
that MSNs expressing mutant htt show an increased
sensitivity to NMDAR activation even from birth, provid-
ing support for the idea that cellular dysfunction could
begin early and that NMDAR activation may be a trigger
of apoptotic cell death in HD.
Enhanced Excitotoxicity Is Neuronal Type
and NMDAR Subtype Specific
To examine whether this enhanced cell death effect was
selective for neurons affected in HD, we repeated these
experiments in cultured cerebellar granule neurons
(CGNs). As found for MSNs, NMDAR-mediated CGN cell
death was concentration dependent [two-factor ANOVA,
effect of concentration F(2,17)  28.6, p  0.0001] (Fig-
ure 3B). In contrast to MSNs, however, primary CGNs
showed no mutant htt-dependent enhancement inFigure 2. Decreased Number of Surviving MSNs in YAC72 Mice
after NMDAR-Induced Excitotoxicity In Vivo NMDAR-mediated cell death as measured by the trypan
The numbers of surviving MSNs and nonpyknotic neurons 72 hr blue assay [two-factor ANOVA, effect of genotype
after intrastriatal injection of quinolinic acid were analyzed using F(1,17) 1.6, p 0.05; genotype concentration inter-
DARPP-32 immunohistochemistry (A, C, and D) and cresyl violet (B), action F(2,17) 0.4, p 0.05] (Figure 3B). It is interesting
respectively. Photomicrographs show DARPP-32 immunostained
that developing CGNs express NR2B, but with matura-coronal sections at the level of the striatum on the lesion (C) and
tion in vivo and in vitro (i.e., by 9 DIV), these neuronscontralateral intact (D) sides (scale bar 40m). Data are presented
express predominantly the NR2A and NR2C NMDARas mean percentage of the number of neurons on the contralateral
unlesioned side (A and B). There was a decreased number of surviv- subtypes (Hollmann and Heinemann, 1994; Monyer et
ing MSNs in both 6- and 10-month-old YAC72 mice (closed bars) al., 1994; Vallano et al., 1996; Thompson et al., 2000;
compared to wild-type mice (open bars). n  3 per group for Kovacs et al., 2001). Thus, our data are consistent with
6-month-old mice, and n  6–7 per group for 10-month-old mice.
the pathology of HD, in which the cerebellum is largelyError bars  SEM. *Significantly different compared to littermate
spared, and support the idea that the excitotoxic en-control, p  0.025.
hancement seen in the mutant mice is NMDAR subtype
dependent.
To ensure that the high NMDA concentration we usedconcentrations in this range have been shown pre-
viously to induce apoptotic death in cultured cortical was not activating other lower affinity receptors, we
treated MSNs with the use-dependent NMDAR antago-neurons (Budd et al., 2000). Similarly to our results in
vivo, MSNs expressing mutant htt were found to be more nist MK-801 together with 3 mM NMDA to specifically
eliminate the contribution of NMDAR activation to cellsensitive to NMDA-mediated cell death in vitro, where
a larger percentage of MSNs were dead 24 hr after death. Under these conditions, cell death was reduced
nearly to baseline levels (i.e., similar to cultures treatedNMDA exposure in cultures from YAC72 compared to
wild-type mice [two-factor ANOVA, effect of genotype with MK-801 alone), confirming that 80% of the cell
death observed in response to 3 mM NMDA resultedF(1,29)  6.9, p  0.05] (Figure 3A). Next, we used the
terminal deoxynucleotidyl transferase-mediated dUTP from NMDAR activation in our system (Table 1). More-
over, we found that a similar proportion (80%) of 3(TUNEL) fluorescein tagged staining technique to exam-
ine NMDAR-induced apoptosis in our cultures, since mM NMDA-induced cell death was inhibited by the NR1/
NR2B subtype-specific antagonist ifenprodil (Williams,previous work has suggested that apoptosis may be the
primary mode of cell death in HD (reviewed by Welling- 1993) for cultured striatal neurons from both YAC72 and
wild-type mice (Table 1). These results are consistentton and Hayden, 2000). In some cases, advanced stages
of degraded necrotic cells can also stain using the TU- with the notion that mutant htt can enhance excitotoxi-
city mediated specifically by the NR1/NR2B subtype ofNEL technique (Trump et al., 1997); therefore, we only
considered as apoptotic TUNEL-positive cells that also NMDAR.
Expression of mutant htt might increase MSN vulnera-had small, condensed nuclei, as visualized with propid-
ium iodide. We found a marked enhancement of bility to a variety of stresses, even though in our experi-
ments cultures were made from early postnatal mice.NMDAR-induced apoptosis among MSNs cultured from
YAC mice expressing mutant htt compared with wild- Therefore, we investigated the effect of another excito-
toxic stress—activation of AMPA receptors—to deter-type mice [two-factor ANOVA, effect of genotype
F(2,40)  14.9, p  0.001], and this enhancement was mine whether the increased vulnerability to cell death
found for mutant htt-expressing MSNs was specific forNMDA concentration dependent [genotype  concen-
tration, F(4,40)  3.4, p  0.05]. Further analysis indi- NMDAR activation. We treated cultured MSNs with 1
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Figure 3. Enhancement of NMDAR-Mediated Cell Death in MSNs Expressing Full-Length Mutant htt Compared to Wild-Type Control MSNs
(A) Survival of MSNs was assessed using the trypan blue exclusion assay 24 hr after exposure to NMDA compared to survival of MSNs that
underwent exposure to salt solution alone. *p 0.05 versus wild-type (WT) at same NMDA concentration. n 4–6 different batches of cultured
neurons for each treatment.
(B) No trend of enhanced NMDAR-mediated cell death in primary cultured CGNs expressing mutant htt compared to wild-type (WT) CGNs.
Survival of CGNs was assessed using the trypan blue exclusion assay 24 hr after exposure to NMDA compared to survival of CGNs that
underwent exposure to salt solution alone. n  3 different batches of cultured neurons for each treatment.
(C and D) The trend in enhancement of NMDAR-mediated apoptosis in MSNs expressing full-length mutant htt compared to wild-type (WT)
MSNs is polyQ-dependent. Representative fields of striatal neurons are shown 24 hr after exposure to salt solution alone (control) or 3 mM
NMDA, followed by TUNEL staining and propidium iodide (PI) counterstaining (C) (scale bar  25 m). In (D), apoptotic MSNs (500) were
assessed using TUNEL staining and morphological criteria as shown by propidium iodide (PI) counterstaining 24 hr after exposure to NMDA
and compared to apoptosis observed in MSNs exposed to salt solution alone. *p  0.05, ***p  0.001 versus wild-type at same NMDA
concentration. #p  0.05 versus 46Q at same concentration. n  3–6 different batches of cultured neurons for each treatment. Bars represent
mean  SEM.
mM AMPA and 50M cyclothiazide (to eliminate AMPAR tant htt compared to wild-type either in the presence or
absence of ifenprodil (Table 2). NMDAR stimulation likelydesensitization and thereby increase toxicity [Brorson
et al., 1995]) in the presence or absence of 10 M ifen- resulted from glutamate released from dying neurons.
Notably, the ifenprodil-sensitive component showed aprodil for 2 hr. Cell death was measured 24 hr later by the
trypan blue assay and the TUNEL assay. Interestingly, trend toward increased cell death for YAC72 compared
with wild-type or YAC46 MSNs, but this difference wasAMPA-stimulated cell death was reduced by 10 M ifen-
prodil and therefore partially mediated by NR2B-sub- not significant. These data confirm that mutant htt en-
hances excitotoxicity mediated by NMDARs but nottype NMDARs (Table 2). However, there was no increase
in AMPAR-mediated cell death in MSNs expressing mu- AMPARs.
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Table 1. Elimination of Excitotoxicity in MSNs after Exposure to NMDAR Antagonists or a Caspase-3-like Inhibitor
3 mM 3 mM NMDA 3 mM NMDA 3 mM NMDA  Number
NMDA  MK-801 IFN z-DEVD-fmk of Trials
Trypan-positive cells (%)
WT 11.4  0.6 1.4  2.2 1.9  2.3 1.7  2.2 3
72Q 29.8  2.8 3.4  2.1 2.3  1.3 2.6  1.2 3–4
TUNEL-positive cells (%)
WT 14.0  0.8 1.9  0.6 1.5  0.6 1.5  1.9 3
46Q 28.5  1.9 3.8  1.1 2.8  0.4 4.2  0.4 3
72Q 33.5  2.6 4.4  1.2 4.9  1.4 2.0  4.2 3–4
NMDAR-Mediated Caspase-3 Activation in MSNs 1.01  0.12 (n  4), indicating that cells expressing
mutant htt and those expressing wild-type htt have simi-Expressing Mutant htt In Vitro
Because caspase-3 activation plays a central role in the lar basal caspase activity. Furthermore, in sister cultures
treated with the caspase inhibitor z-DEVD-fmk just be-regulation of neuronal death in the CNS, we examined
caspase-3 activity in the primary striatal cultures after fore, during, and after NMDAR stimulation, we noted a
significant decrease in activation of caspase-3 (Figuresexposure to NMDA or glutamate. Using immunocyto-
chemistry to detect the active form of caspase-3, we 4A and 4B) and in cell death of MSNs (Table 1). Our
results demonstrate that NMDAR activation is an effec-observed a significantly larger increase in its expression
6 hr after a brief application of 3 mM NMDA in YAC46 tive stimulus of caspase-3 activity in cultured MSNs,
which is required for mediating NMDA-induced celland YAC72 MSNs compared to wild-type controls [two-
factor ANOVA, effect of genotype F(2,47)  7.1, p  death. Moreover, the enhanced NMDAR-induced cas-
pase-3 activity observed in MSNs expressing mutant htt0.01] (Figures 4A and 4B). As well, there was a trend
toward a larger increase in NMDAR-induced caspase- compared with wild-type controls correlates well with
enhanced apoptosis shown by the TUNEL staining tech-3 activity for YAC72 versus YAC46 MSNs, which was
not significant because of the variability in absolute per- nique (see Figures 3C and 3D).
centages of immunopositive neurons between different
batches of cultured MSNs. The difference between wild- Enhanced NMDAR-Mediated Peak Current
type and YAC72 MSNs was replicated using a fluoromet- Density in Acutely Dissociated MSNs
ric assay for caspase activity; we found a significant Expressing Mutant htt
enhancement of caspase activation in cultured striatal Increased sensitivity to NMDAR-mediated excitotoxicity
cell lysates from YAC72 compared to wild-type mice 3 might be secondary to mutant htt: (1) increasing activity
and 6 hr after exposure to 3 mM NMDA [two-factor of NMDARs in response to stimulation, or (2) modulating
ANOVA, effect of genotype F(1,14)  34.8, p  0.001 at processes downstream of NMDAR activation (e.g., mito-
3 hr and F(1,14)  7.1, p  0.05 at 6 hr] (Figure 4C). chondrial function or calcium homeostasis). Our previ-
Together, these results (Figure 4) are consistent with ous work in a nonneuronal cell line indicated that expres-
the TUNEL staining data (Figures 3C and 3D), indicating sion of mutant htt increased NMDAR-evoked current
that NMDA-induced apoptotic death is significantly (Chen et al., 1999). Therefore, we tested the hypothesis
higher for MSNs cultured from YAC72 mice compared that an increase in NMDAR activity in MSNs of YAC72
with wild-type mice. Notably, the ratio of caspase activ- mice underlies the increased sensitivity to excitotoxic
ity measurements in wild-type controls to 72Q controls cell death by recording NMDA-evoked current in a
measured 6 hr after exposure to salt solution alone was blinded fashion from striatal neurons acutely dissoci-
ated from the brains of 6- to 11-week-old YAC72 mice
versus wild-type littermates. Using the whole-cell patch
Table 2. No Trend in Enhancement of Non-NMDAR-Mediated clamp recording technique under voltage clamp, we
Excitotoxicity in MSNs Expressing Mutant htt Compared to
found that50% of the peak current evoked by applica-WT MSNs
tion of 1 mM NMDA and 50 M glycine was blocked by
1 mM AMPA 1 mM AMPA  Number 10 M ifenprodil (e.g., Figure 5A), a dose that selectively
 cyclothiazide cyclothiazide  IFN of Trials inhibits current mediated by NR1/NR2B-type but not
Trypan-positive cells (%) NR1/NR2A-type NMDARs (Williams, 1993). Strikingly,
WT 29.8  3.0 16.4  1.8 4 we observed significantly larger NMDAR peak current
46Q 26.8  4.3 14.0  3.8 4 amplitudes and current density (amplitude normalized to
72Q 34.2  1.3 14.8  1.3 2
membrane capacitance to take into account variability inTUNEL-positive cells (%)
cell size) in MSNs from the YAC72 mice (Figure 5B).WT 37.8  10.2 18.8  5.1 4
Mean cell capacitance measured for the two groups46Q 37.5  4.6 21.1  3.1 5
72Q 47.5  1.1 12.6  6.2 2 was not significantly different (3.27  0.19, n  42 and
3.07  0.18, n  39 for YAC72 and wild-type, respec-Analysis of trypan blue data: two-factor ANOVA; effect of ifenprodil
tively). These data are consistent with our previous find-F(1,19) 26.5, p 0.001; effect of genotype F(2,19) 0.7, p 0.05;
genotype  ifenprodil interaction F  0.4, p  0.05. Analysis of ings in a nonneuronal cell line (Chen et al., 1999) and
TUNEL data: effect of ifenprodil F(1,21)  17.8, p  0.001; effect of suggest that increased NMDAR-induced sodium and
genotype F(2,21) 0.03, p 0.05; genotype ifenprodil interaction calcium influx may play a role in enhanced susceptibility
F  0.9 , p  0.05.
to cell death. This result does not rule out that other
Neuron
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Figure 4. Increase in NMDA-Mediated Caspase-3 Activation in MSNs Expressing Full-Length Mutant htt Compared to Wild-Type Controls
(A) Caspase-3 activation was assessed by in situ immunofluorescence 6 hr after exposure to salt solution [C] or 3 mM NMDA [A], with or
without 10 M z-DEVD-fmk [I], in MSNs expressing mutant htt (72Q) compared to control MSNs. DAPI staining in blue represents total nuclei
present, and red indicates staining for activated caspase-3. MSNs are shown in phase contrast (upper panels) or in fluorescence (lower
panels). Bar  20 m.
(B) Enhancement of NMDAR-dependent caspase-3 activation is also polyQ length-dependent, as assessed by in situ immunofluorescence 6
hr after exposure to experimental solutions. **p  0.01, ***p  0.001 versus wild-type (WT) at same NMDA concentration. n  3–5 different
batches of cultured neurons for each treatment.
(C) Enhancement of NMDAR-dependent activation of caspase proteolysis in cultured striatal cells expressing full-length mutant htt (72Q)
compared to wild-type (WT) control. Caspase activation was assessed fluorometrically by cleavage of Ac-DEVD-AFC 3 and 6 hr after exposure
to NMDA, normalized to background fluorescence and amount of protein/sample, and compared to sister cultures that underwent exposure
to salt solution alone. **p  0.01, ***p  0.001 versus wild-type at same NMDA concentration. n  3–5 different batches of cultured neurons
for each treatment and time point.
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served for medium-sized spiny striatal neurons (Levine
et al., 1999; Laforet et al., 2001). In contrast, we found
no significant difference in mean cell capacitance mea-
sured for wild-type versus YAC72 neurons, indicating
that the total membrane area recorded from was equiva-
lent, and we observed that the dendritic trees remaining
after acute dissociation appeared similar for the two
groups.
In previous studies, electrophysiological recordings
from MSNs in acute striatal slices have suggested only
a very minor role for NMDARs in routine cortico-striatal
synaptic activity, due to the hyperpolarized resting mem-
brane potential measured for these neurons (Calabresi et
al., 1987) and voltage-dependent Mg2 block of NMDARs
(Hollmann and Heinemann, 1994). On the other hand,
measurements made in vivo indicate that MSNs show
spontaneous depolarizations of membrane potential
and that the role of NMDARs in cortico-striatal MSN
synaptic transmission may be substantial during such
times (Cepeda and Levine, 1998; Calabresi et al., 2000).
Therefore, it is plausible that an increase in NMDAR-
mediated current in response to synaptic stimulation,
resulting in an increased intracellular calcium load, may
Figure 5. Increased Peak NMDA-Evoked Current Recorded from chronically stress MSNs expressing mutant htt. The
Acutely Dissociated YAC72 Striatal Neurons Compared with Wild-
increase in cell stress resulting from the mutant htt-Type Controls
induced increase in NMDAR activity would be one candi-(A) Representative traces of NMDA-evoked current recorded from
date mechanism for contributing to the “mutant steady-a single wild-type (WT) or 72Q MSN. Bar represents application of
state” in human HD suggested by Clarke et al. (2000).1 mM NMDA in the presence of 50 M glycine. In the right panel,
“control” indicates application of NMDA alone, and “ifenprodil” indi- As well, this increased stress from the earliest ages
cates application of NMDA with 10 M ifenprodil. Note that 50% could be consistent with late onset neurodegeneration,
of peak current is inhibited by ifenprodil, indicating that the majority since the aging process is associated with a progressive
of current is carried by NR1/NR2B-type NMDARs. decrease in the ability of cells to compensate for oxida-(B) Peak current density for 1 mM NMDA-evoked currents recorded
tive stress (reviewed by Beal, 1992).from MSNs acutely dissociated from the striata of 6- to 11-week-
It has been proposed that presynaptic mechanisms,old animals. Bars represent mean  SEM measured from n  39
and 42 different cells from 10 and 13 different animals for wild-type such as aberrant activity and/or increased release of
(WT) and YAC72, respectively. *p 0.015 compared with wild-type, glutamate from cortical afferents, might contribute to
using unpaired t test. degeneration of striatal neurons in mice expressing mu-
tant htt (Gutekunst et al., 1999; Li et al., 2000). Recent
data indicate mitochondrial dysfunction in YAC72 mice
intracellular processes downstream of NMDAR activa- (T. Greenamyre, personal communication), and MSNs
tion might also be altered by mutant htt and contribute from another model of HD, the R6 mice, tend to have
to increased sensitivity to excitotoxicity. depolarized resting membrane potentials (Levine et al.,
1999), which would facilitate activation of NMDARs. As
well, previous studies in late-stage symptomatic miceDiscussion
expressing N-terminal fragments of mutant htt, and in
older (1–2 years) YAC72 mice, have also shown a trendEnhanced NMDAR Activity May Contribute
toward increased NMDAR currents recorded from stria-to the Mutant Steady State in HD
tal neurons (Cepeda et al., 2001a; Laforet et al., 2001).Here, we have demonstrated that mutant htt increases
Our data strongly support a role for mutant htt in enhanc-sensitivity of striatal MSNs to excitotoxic cell death in-
ing responsiveness of postsynaptic NMDARs in MSNs,duced by NMDAR activation in a transgenic mouse
even in very young, presymptomatic animals; this mech-model of HD, addressing a long-standing question re-
anism could act synergistically with presynaptic pro-garding the role of excitotoxicity in the pathogenesis of
cesses, mitochondrial dysfunction, and postsynapticHD. One potential mechanism underlying this enhanced
membrane depolarization to facilitate degeneration ofsusceptibility of MSNs to NMDA is the increase in
MSNs.NMDAR current we observed in MSNs expressing mu-
tant htt. YAC72 neurons would be expected to be as
healthy as wild-type neurons in the young (6- to 11- Potential Molecular Interactions between
NMDARs and httweek-old) mice used for these studies, since neuronal
degeneration does not occur in this line until after 6 Our data (see Figure 3) suggest that mutant htt effects
little, if any, change in the EC50 for NMDA-induced cellmonths of age. Therefore, our results are unlikely to be
caused by secondary effects of cell stress due to other death, but a robust increase in maximal toxicity. This
result parallels studies of modulation of glutamate re-pathways. In the R6/2 mice, reduced membrane area
and truncated dendritic trees and spines have been ob- ceptor currents by protein kinases, which also induce
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a large potentiation of the maximal current response toxicity in R6 mice (Hansson et al., 2001). These data
suggest that R6 neurons are under chronic stress andwith little or no change in EC50 (Wang et al., 1993, 1994).
The mechanism of NMDAR current potentiation by mu- have developed compensatory mechanisms that dimin-
ish the damage of excitotoxic insults (Hansson et al.,tant htt has not been addressed in the present studies;
however, preliminary results suggest that expression 2001). YAC72 mice and patients with advanced HD ex-
hibit intranuclear inclusions in a small percentage oflevels of NR1 and NR2B are not increased in striatal
tissue from 6- to 12-week-old YAC46 or YAC72 mice striatal neurons (Hodgson et al., 1999; Sapp et al., 1999),
and, therefore, these mice may constitute a more rele-compared with wild-type (C.D. Icton and L.A.R., unpub-
lished data). On the other hand, recent data indicate vant disease model.
that htt may associate with NMDARs within a larger
complex via direct interaction with postsynaptic density Enhanced Excitotoxicity as a Trigger of
protein-95 (PSD-95) (Sun et al., 2001) or through interac- Downstream Events in the Pathogenesis of HD
tions with huntingtin-interacting protein 1 (HIP-1) and The data presented here identify NMDAR activation as
-actinin (C.D. Icton and L.A.R., unpublished data). It a trigger for enhanced caspase activation and cell death
is possible that mutant htt increases NMDAR current in striatal MSNs expressing mutant versus wild-type htt.
and sensitivity to NMDAR-mediated excitotoxicity by In this regard, a variety of studies suggest a strong role
interacting with these cytoskeletal associated proteins, for caspase activation in neuronal degeneration in HD
which are known to modulate NMDAR channel function (Ona et al., 1999; Sanchez et al., 1999; Wellington and
and/or subcellular localization (Scannevin and Huganir, Hayden, 2000). Furthermore, minocycline, an inhibitor
2000). of caspase-1 and -3, delays death in the R6 mice (Chen
et al., 2000), and intracerebral infusion of caspase inhibi-
tors or crossing R6/2 mice with a mutant mouse domi-Differential Sensitivity to NMDAR-Induced
Excitotoxicity of R6 and YAC72 Mice nant-negative for caspase 1 have both been reported
to inhibit development of the R6 phenotype (Ona etIn contrast to the present results obtained in YAC72
mice, intrastriatal injection of quinolinic acid in the trans- al. 1999). Our results indicate that increased NMDA-
induced caspase-3 activation and cell death, as well asgenic R6 mouse models of HD (Mangiarini et al., 1996)
resulted in significantly less neuronal degeneration and increased NMDAR-mediated currents, occur in mutant
htt-expressing MSNs as early as the first few weeksapoptosis compared with wild-type littermates (Hans-
son et al., 1999). The resistance developed gradually postnatal, strongly supporting a primary role for exces-
sive NMDAR stimulation in MSN degeneration in HD.with age and more rapidly in R6/2 (150 CAG repeats)
than R6/1 mice (115 CAG repeats) (Hansson et al., 2001). A large body of evidence in in vitro models suggests
that cellular accumulation of short fragments of theR6 mice and YAC72 mice differ in many respects, includ-
ing: (1) R6 mice express only a small fragment (3% of N-terminal region of htt containing the polyQ tract can
cause neuronal dysfunction and/or death (Cooper et al.,the total length) of the htt protein, whereas YAC trans-
genics express the full-length protein; (2) htt expression 1998; Hackam et al., 1998; Martindale et al., 1998; Li et
al., 1999). Huntingtin is cleaved by caspase-3 and -6,is controlled by some but not all of the regulatory ele-
ments contained in the 5	 untranslated region of the as well as calpains (Wellington et al., 2000; Kim et al.,
2001; J. Gafni and L.M. Ellerby, submitted; C.L.W., un-human gene for R6 mice, but all regulatory elements are
included in controlling expression of htt in YAC mice; published data) in the brains of normal controls as well
as patients symptomatic with HD. Our data showing(3) the number of CAG repeats in the HD gene is twice
as large for R6/2 mice as for YAC72 transgenics; and enhanced NMDAR-induced caspase-3 activation in mu-
tant htt-expressing striatal neurons suggest NMDAR ac-(4) R6 mice show widespread and abundant intranuclear
inclusions, whereas those found in brains of YAC trans- tivity as a potential trigger for increased htt cleavage.
We have observed a high basal level of htt cleavagegenics are more sparse and restricted in distribution.
We have shown previously that while expression of full- products and little difference in the extent of cleavage in
cultured murine MSNs across different genotypes (wild-length mutant htt with 138Q significantly increased
NMDAR-mediated cell death in a cell line, an N-terminal type, YAC46, and YAC72) or treatment conditions (NMDA
versus buffered salt solution) by Western blot analysisfragment (540 amino acids) of htt had less effect (Zeron
et al., 2001). Thus, it is possible that the full context of using multiple N-terminal htt antibodies (our unpub-
lished data). Additionally, we have observed no increasethe mutant htt protein is required to increase NMDAR-
mediated cell death and that these initial steps of patho- in immunodetection of caspase-2/3 htt cleavage frag-
ments in striatal tissue in vivo following quinolinate injec-genesis in HD are bypassed in the R6 mice. On the
other hand, recent data suggest that NMDARs in striatal tion (B.R.L. and C.L.W., unpublished data). However,
because the sites for many of the proteases that cleaveneurons of R6/2 mice show increased activity, in part
due to decreased sensitivity to Mg2block, at ages when htt are tightly clustered and some are indistinguishable
(i.e., caspase-3 and caspase-2), it may not be possiblesymptoms and htt aggregates are present (Cepeda et
al., 2001a). Why then are the R6 striatal neurons resistant to use htt as the sole marker to detect a shift from one
proteolytic pathway to another upon NMDAR activationto NMDAR-mediated excitotoxicity? One likely explana-
tion is the widespread intranuclear aggregation of htt in using currently available antibodies. Rather, our results
suggest that the mutant htt-induced increase in cas-up to 90% of these neurons (Davies et al., 1997), since
we have recently correlated the development of nuclear pase-3 activation following NMDA treatment in our
model of acute excitotoxicity may result in cleavage ofinclusions and more efficient handling of Ca2 increases
with the appearance of resistance to NMDAR-induced many additional substrates that together lead to death
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of MSNs, consistent with the accepted role for cas- et al., 1996; Thompson et al., 2000; Kovacs et al., 2001);
and (3) the majority of NMDA-evoked current in MSNspase-3 in neuronal cell death in the CNS.
was sensitive to the NR2B-specific antagonist ifen-
prodil, and NMDA-mediated excitotoxic cell death wasIncreased NR2B-Subtype NMDAR Activity May
nearly eliminated by treatment with this antagonist. Se-Explain Selective Neuronal Degeneration
lective enhancement of NR1/NR2B-type NMDAR activ-Our results shed light on the issue of how a family of
ity by mutant htt may, in part, explain selective vulnera-autosomal dominant hereditary neurodegenerative dis-
bility of striatal MSNs to neurodegeneration in HD.orders, each caused by a (different) gene encoding an
Moreover, our results suggest that NMDAR antagonistsexpanded polyglutamine repeat within a protein of wide
specific for the NR1/NR2B subtype may show higherCNS distribution, may show selective neuronal vulnera-
efficacy in slowing progression of this disease than thebility in distinct brain regions (for review, see Tobin and
less specific inhibitors of glutamatergic transmissionSigner, 2000). We propose that the upstream events
tested thus far.triggering the probable final common pathway in these
diseases may be unique for each disease and related
Experimental Proceduresto interactions between the mutant protein and other
proteins that are selectively expressed in vulnerable YAC Transgenic Mice
neuronal populations. By using the YAC transgenic In vivo experiments were performed using heterozygous YAC72
mouse model of HD, in which selective neuronal degen- mice from line 2511 (as described by Hodgson et al., 1999), at ages
6 and 10 months, derived from a pure FVBN/NJ strain background.eration so closely parallels that found in the human dis-
The control mice were nontransgenic littermates. Only crosses be-ease (Hodgson et al., 1999), we have been able to ad-
tween two homozygous YAC transgenic mice, designed as de-dress this issue.
scribed previously by Hodgson et al. (1999), or between homozy-Within the striatum, the vulnerable MSNs display im- gous YAC and wild-type mice were used to make neostriatal
portant differences in NMDAR subunit composition and cultures. YAC46 (46Q; 668 line) or YAC72 (72Q; 2511 line) mice were
electrophysiological characteristics compared to the used as models expressing full-length mutant htt and compared to
FVB wild-type mice.population of aspiny cholinergic neurons, which are rela-
tively resistant to degeneration in HD. MSNs express
Lesion Surgerymainly NR1A and NR2B, a receptor complex previously
Quinolinic acid (Sigma, Sweden) was dissolved in 0.1 M phosphateshown to be modulated by mutant htt, whereas choliner-
buffered saline (pH 7.4). Under halothane anesthesia, the mice re-
gic interneurons express mainly NR2D with NR1 (Land- ceived intrastriatal injections of 8 nmol of quinolinic acid (0.8 l).
wehrmeyer et al., 1995; Chen et al., 1999; Kuppenbender Using a 2 l Hamilton microsyringe fitted with a glass micropipette
et al., 1999). As well, MSNs respond with markedly larger (outer diameter 60–80 m), injections were made into the right stria-
tum at the following stereotaxic coordinates: 0.9 mm rostral toamplitude membrane depolarization to exogenous ap-
bregma, 2.0 mm lateral to midline, 3.2 mm ventral from the boneplication of AMPA, kainate, and NMDA receptor agonists
surface, with the tooth-bar set at zero. The toxin was injected overcompared with striatal cholinergic neurons; this in-
5 min, and thereafter, the cannula was left in place for an additional
creased responsiveness may be one mechanism for in- 5 min to minimize the risk of the retrograde leakage of toxin. Body
creased MSN vulnerability to cell death in ischemia or temperature was controlled using a heating pad set at 37
C. There
neurodegenerative diseases (reviewed by Calabresi et was no mortality of mice in conjunction with surgery.
al., 2000; Cepeda et al., 2001b).
Neuronal CultureIt is interesting that the regional variation in severity
Anterior striata were dissected, using landmarks previously de-of neuronal degeneration in HD—striatum  cortex 
scribed (Howe and Surmeier, 1995), from postnatal day 0–1 (P0–P1)cerebellum and brainstem (Vonsattel and DiFiglia,
mice in ice-cold divalent-free Hank’s Balanced Salt Solution
1998)—correlates well with the relative expression levels (GIBCO), then diced and dissociated with 0.25% trypsin-EDTA
of NR2B compared with other NR2 subunits (Hollmann (GIBCO) using a series of reducing bore-size Pasteur pipettes. After
and Heinemann, 1994; Monyer et al., 1994; Portera-Cail- enzyme inhibition with 10% heat-inactivated fetal bovine serum
(GIBCO) in Neurobasal medium (GIBCO), cells were plated at aliau et al., 1996; Thompson et al., 2000). We would pre-
density of1 106 cells/mL on poly-D-lysine (MW 30,000–70,000dict that neurons expressing NR2B at lower ratios to
g/mol; 250 g/mL final concentration) coated dishes with or withoutother NR2 subunits than MSNs, such as pyramidal neu-
nitric acid-treated 12 mm round coverslips in plating medium con-
rons of the cortex and hippocampus, might show a taining Neurobasal media, B27 (GIBCO), 100 units/ml penicillin-
smaller increase in NMDAR-mediated current and exci- streptomycin (GIBCO), and 2 mM -glutamine and maintained at
totoxicity in the YAC72 mice. Further experiments are 37
C, 5% CO2 with humidity. Cells were fed 3 days after plating
with medium lacking -glutamine.required to test this prediction, and the results would
Cerebella were dissected from P8 mice following a similar proto-help determine whether NR2B expression is sufficient
col as for the MSNs, with a few changes. Trypsin action was endedor if other downstream factors contribute to selective
with plating medium containing Basal Medium Eagle with Earle’s
neuronal vulnerability in HD. Salts and NaHCO3, 10% heat inactivated fetal calf serum (GIBCO),
In conclusion, we propose that mutant htt selectively 100 units/mL penicillin-streptomycin, 2 mM -glutamine, 17 mM
enhances activity and toxicity of NR1/NR2B-type D-glucose, and 25 mM KCl. Cells were plated at 2.0  106 cells/mL
and examined 8–9 DIV.NMDARs, as supported by our data in neuronal cultures
showing: (1) no difference between wild-type and YAC72
Induction of Cell Deathstriatal medium spiny neuron death upon selective acti-
After 9–12 DIV, cultured MSNs were exposed for 10 min to varyingvation of AMPARs; (2) no difference between wild-type
NMDA concentrations (30, 100, and 3000M) in triplicates or greater
and YAC72 cerebellar granule neuron death upon stimu- in the presence of 50 M glycine in a physiological salt solution:
lation of NMDARs, which are composed of NR1 with 134 mM NaCl, 2.5 mM KCl, 4 mM NaHCO3, 5 mM HEPES, 2.3 mM
CaCl2, 5.5 mM D-glucose, and phenol red, or exposed to salt solutionNR2A and/or NR2C, but do not include NR2B (Vallano
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alone (control). Cells were then rinsed with plating media, the original in 4% NGS in PBS (a kind gift of Drs. Donald Nicholson and Sophie
Roy) overnight at 4
C in a humidified chamber. After washing three(conditioned) plating media was replaced, and cells were maintained
in humidified 5% CO2 at 37
C. An additional set of sister cultures times in PBS, coverslips were then incubated with Alexa 594-conju-
gated goat anti-rabbit secondary antibody in 4% NGS in PBS forthat did not undergo the procedure were also maintained under the
same conditions (untreated). Some cultures underwent exposure to 30 min at room temperature, followed by three washes in PBS. Cells
were counterstained with DAPI and mounted on glass slides. Images20 M MK-801 or 10 M ifenprodil in conditioned media for 30 min
before agonist exposure, in the agonist solution, as well as after were captured using a CCD camera using Prince (Northern Eclipse)
software.exposure. Other experiments utilized 10 M caspase inhibitor
z-DEVD-fmk (Calbiochem), requiring a 1 hr pretreatment, with addi-
tions during and after agonist exposure. For experiments examining
Caspase Activity Assaynon-NMDAR-mediated cell death, MSNs underwent a 2 hr exposure
As described by Wellington et al. (2000), we measured DEVD-aseto 1 mM AMPA (Tocris) and 50 M cyclothiazide, with or without
activity with the ApoAlert fluorometric kit (Clontech) in MSN primary10 M ifenprodil, and were examined for cell death 24 hr later. At
cultures. At various time points following NMDA exposure, we har-8–9 DIV, CGNs underwent exposure to NMDA for 30 min, then were
vested the cells, lysed them with cell lysis buffer (Clontech), andrefreshed with serum-omitted media, and examined for cell death
collected the supernatant. Protein concentration in the supernatant24 hr later.
was measured using the Lowry assay. The supernatant was incu-
bated with reaction mixture containing DEVD-AFC from ClontechCell Death Assays
and compared to control samples that were inhibited with DEVD-YAC72 mice and littermate controls were transcardially perfused
CHO and to substrate blanks. Caspase activity was measured fluo-with 4% paraformaldehyde 72 hr after intrastriatal injection of QA.
rometrically every 5 min for 1 hr at 37
C at excitation wavelengthCoronal brain sections were cut (30 m) and stained for Fluoro-
390 nm and emission wavelength 510 nm. The linear range of rateJade as previously described by Hansson et al. (1999). Fluoro-Jade
of change in fluorescence was normalized to protein concentrationis a marker for degenerating neurons (Schmued et al., 1997) and
and expressed as relative levels and compared to measurementscorrelates strongly with the number of TUNEL-positive cells after
from cells that underwent exposure to salt solution alone.intrastriatal injection of quinolinic acid in mice (Hansson et al., 1999).
The sections were also processed for DARPP-32 immunohisto-
chemistry to evaluate the number of surviving MSN (Hansson et al., Electrophysiology
1999). In addition, the number of surviving nonpyknotic cells was Acute dissociation of neostriatal neurons was performed as pre-
investigated on cresyl violet-stained sections. The quantification of viously described (Howe and Surmeier, 1995) with a few changes.
cells was performed using an unbiased stereology method and the Using a Leica microtome (Leica VT 1000 S, Germany), 400 m slices
CAST-Grid system (Olympus Denmark A/S, Albertslund, Denmark) were made from freshly dissected brain tissue bathed in slicing
(West et al., 1991). Cell loss in the striatum was examined in every buffer (SB) that contained 127 mM NaCl, 3 mM KCl, 1.5 mM MgCl2,fifth section (120 m apart) in a region starting caudally at the level 1 mM CaCl2, 17.5 mM glucose, 19.5 mM NaHCO3, 1.5 mM NaH2PO4,of the ventral hippocampal commissure and extending rostrally up 1 mM kynurenic acid, 1 mM pyruvic acid, 0.1 mM N-nitroarginine,
to the level of the genu of the corpus callosum. This encompasses and 5 mM glutathione (pH 7.4 and osmolarity 300 mosm/l). Slices
the major portion of the head and tail of the caudate-putamen, and were incubated for 1–5 hr at room temperature in SB continuously
typically 12 sections were examined per brain. bubbled with 95% O2 and 5% CO2. Then, in triturating buffer (TB)In striatal cultures, the trypan blue inclusion assay was done 24 containing 140 mM Na isethionate, 2 mM KCl, 4 mM MgCl2, 23 mMhr after exposure to NMDA. Trypan blue dye (0.4%) was added to Glucose, 15 mM HEPES, 5 mM glutathione, 1 mM kynurenic acid,
the cultures, and 10 random photographs of different brightfield 1 mM pyruvic acid, and 0.1 mM N-nitroarginine, regions of the dorsal
(250) images per dish were taken. The photographs were blind neostriatum were carefully microdissected and kept in humidified
coded and quantified for total cell numbers and number of trypan 5% CO2 at 37
C. After 10 min digestion with papain, tissue was rinsedblue-positive cells; only cells that met the morphological criteria for in enzyme free TB and mechanically dissociated with a graded series
MSNs were scored. Values were averaged per condition, and total of fire-polished Pasteur pipettes. Cells were used for electrophysio-
cell numbers were compared within a condition group and between logical analysis 5–10 min after plating onto coverslips. Patch clamp
conditions. The percentage of trypan blue-positive cells in cultures recording techniques were similar to those previously described
that underwent exposure to salt solution alone was subtracted from (Chen et al., 1997). Coverslipped acutely dissociated striatal neurons
the percentage of trypan blue cells measured after NMDA treatment. were set in the recording chamber on the stage of an inverted
Neuronal loss in the control (salt solution alone) was minimal (5%) microscope (Aviovert 100; Carl Zeiss, Thornburg, NY). During whole-
and comparable with that of the untreated group. cell recording mode under voltage clamp (VH  60 mV), neuronsFor the fluorescent TUNEL assay, 24 hr after the MSN cultures were lifted to achieve fast perfusion achieved by a piezo-driven
grown on coverslips were exposed to NMDA, they were fixed for 1 theta tube (Hilgenburg, Malsfeld, Germany). In all experiments, 50
hr in a 4% paraformaldehyde solution (pH 7.3). Cells were stained
M glycine was added to both control and NMDA-containing extra-
with TUNEL mixture as described by Roche Diagnostics or with cellular solutions. The intracellular recording solution contained 120
label solution alone (negative control), counterstained with 4 M mM CsMeSO4, 5 mM 1,2-bis(2-aminophenoxy)ethane N,N,N	,N	-tetra-propidium iodide (PI) (Molecular Probes), and incubated with Slow- acetic acid, 3 mM MgATP, 1 mM MgCl2, 0.3 mM GTP-tris, and 10Fade from the Antifade Kit (Molecular Probes) according to manu- mM HEPES (titrated to pH 7.25 with CsOH). Extracellular recording
facturer’s instructions. The number of TUNEL-positive cells was solution contained 145 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 11compared to the total number (500) of PI-positive cells in randomly mM glucose, and 10 mM HEPES (titrated to pH 7.35 with 10 M
chosen microscopic fields after blindly counting only cells showing NaOH). 10M CNQX and 0.1M TTX were added to the extracellular
condensed nuclei and resembling MSNs. The percentage of apo- recording solution immediately before each experiment to block
ptotic cells in the control solution group was subtracted from the AMPA/kainate-type glutamate receptors and voltage-gated sodium
percentage of apoptotic cells after exposure to NMDA for each currents, respectively. Currents were sampled at 2 kHz and acquired
respective genotype. and analyzed using pCLAMP software and the Axopatch 200A am-
plifier (Axon Instruments, Foster City, CA). Current amplitude mea-
Caspase-3 Immunofluorescence surement and kinetics fitting were conducted with Clampfit
MSNs were cultured on coverslips and treated for the caspase activ- software.
ity measurements as above. After recovery for 6 hr, cells were rinsed
with PBS and fixed in freshly prepared 4% paraformaldehyde in
PBS, rinsed in PBS, permeabilized with 0.5% Triton-X100 in PBS, Statistical Analysis
Significant differences were determined using the two-factor ANOVAwashed in PBS, and blocked with 4% normal goat serum (NGS) in
PBS for 30 min. Coverslips were then incubated with a polyclonal followed by Bonferroni-Dunn’s post hoc test for pairwise compari-
sons, unless otherwise noted.antibody specific for the cleaved and activated form of caspase-3
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